Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning-Reference-Cited by-同舟云学术

Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning

Published:2003-01 Issue:1 Volume:31 Page:73-80
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Lee Choon-Kee,Badros Ashraf,Barlogie Bart,Morris Christopher,Zangari Maurizio,Fassas Athanasios,van Rhee Frits,Cottler-Fox Michele,Jacobson Joth,Thertulien Raymond,Muwalla Firas,Mazher Syed,Anaissie Elias,Tricot Guido

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference23 articles.

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med.,1996

2. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma;Barlogie;Blood.,1997

3. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma;Lenhoff;Nordic Myeloma Study Group. Blood.,2000

4. Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants;Tricot;Br J Haematol.,2002

5. Results of high-dose therapy for 1000 patients with multiple myeloma;Desikan;Blood.,2000

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?;Journal of Clinical Medicine;2020-07-23

2. Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?;Journal of Clinical Medicine;2020-07-10

3. Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation;Clinical Transplantation;2017-05-26

4. Adverse impact of high donor CD3+ cell dose on outcome following tandem auto-NMA allogeneic transplantation for high-risk myeloma;Bone Marrow Transplantation;2017-03-20

5. Allogeneic transplantation in multiple myeloma – How, when or at all?;Acta Haematologica Polonica;2015-05